escape recognition by the innate immune system. We have previously demonstrated that spontaneous loss of GPL converts M. abscessus to an immunostimulatory phenotype capable of invading and replicating in fibroblasts and macrophages [8,9,12,13,17]. We now extend our observations by demonstrating that M. abscessus variants lacking GPL are recognized by TLR2 on respiratory epithelial cells resulting in release of IL-8 and expression of HbD2. Based on these results and those of prior studies, we propose that M. abscessus variants expressing GPL are able to colonize abnormal upper airways in patients with bronchiectasis without evoking an immune response. This enables the bacteria to establish a foothold in the lung. Spontaneous mutants lacking GPL, arising from these colonizing bacteria, then enter the alveolar space where they cause References 1. Howard ST, Byrd TF (2000) The rapidly growing mycobacteria: saprophytes and parasites. Microbes Infect 2: 1845–1853. 2. De Groote MA, Huitt G (2006) Infections due to rapidly growing mycobacteria. Clin Infect Dis 42: 1756–1763. 3. Griffith DE, Girard WM, Wallace RJ (1993) Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 147: 1271–1278. 4. Fauroux B, Delaisi B, Clement A, Saizou C, Moissenet D, et al. (1997) Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J 16: 354–358. 5. Cullen AR, Cannon CL, Mark EJ, Colin AA (2000) Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? Am J Resp Crit Care 161: 641–645. 6. Olivier KN, Weber DJ, Wallace RJ, Faiz AR, Lee JH, et al. (2003) Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Resp Crit Care 167: 828–834. 7. Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, Offredo C, Guillemot D, et al. (2003) Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis 9: 1587–1591. 8. Howard ST, Rhoades E, Recht J, Pang X, Alsup A, et al. (2006) Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology 152: 1581–1590. 9. Rhoades ER, Archambault AS, Greendyke R, Hsu F, Streeter C, et al. (2009) Mycobacterium abscessus glycopeptidolipids mask underlying cell wall phosphatidyl- myo-inositol mannosides blocking induction of human macrophage TNF-a by preventing interaction with TLR2. J Immunol 183: 1997–2007. 10. Ripoll F, Deshayes C, Pase S, Laval F, Beretti J, et al. (2007) Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae. BMC Genomics 8: 114. 11. Medjahed H, Reyrat J (2009) Construction of Mycobacterium abscessus defined glycopeptidolipid mutants: Comparison of genetic tools. Appl Environ Micro 75: 1331–1338. 12. Byrd TF, Lyons CR (1999) Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection. Infect Immun 67: 4700–4707. 13. Nessar R, Reyrat J, Davidson LB, Byrd TF (2011) Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response. Microbiology 157: 1187–1195. 14. Krutzik SR, Modlin RL (2004) The role of Toll-like receptors in combating mycobacteria. Semin Immunol 16: 35–41. 15. Bals R, Hiemstra PS (2004) Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 23: 327–333. 16. Birchler T, Seibl R, Buchner K, Loeliger S, Seger R, et al. (2001) Human Toll- like receptor 2 mediates induction of the antimicrobial peptide human beta- defensin 2 in response to bacterial lipoprotein. Eur J Immunol 31: 3131–3137. 17. Greendyke R, Byrd TF (2008) Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. Antimicrob Agents Ch 52: 2019–2026. 18. Kinnula VL, Yankaskas JR, Chang L, Virtanen I, Linnala A, et al. (1994) Primary and immortalized (BEAS 2B) human bronchial epithelial cells have significant antioxidative capacity in vitro. Am J Resp Cell Mol 11: 568–576. 19. Chmura K, Bai X, Nakamura M, Kandasamy P, McGibney M, et al. (2008) Induction of IL-8 by Mycoplasma membrane in BEAS-2B cells. Am J Physiol - Lung C 295: L220–L230. Glycopeptidolipid Prevents TLR2 Signaling invasive lung infection and provoke an inflammatory response. It is possible that additional defects in the immune recognition and/ or response are present in subsets of patients with bronchiectasis which result in an inability to clear these rough variants once invasive infection is established in the lung parenchyma. This is currently being investigated in our laboratory. Author Contributions Conceived and designed the experiments: TB LD PK. Performed the experiments: LD PK. Analyzed the data: TB LD PK DP. Contributed reagents/materials/analysis tools: RN. Wrote the paper: TB LD. 20. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 25: 402–408. 21. Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, et al. (2000) Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 164: 554–557. 22. Underhill DM, Ozinsky A, Smith KD, Aderem A (1999) Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 96: 14459–14463. 23. Takeuchi O, Sato S, Ooriuchi T, Hoshino K, Takeda K, et al. (2002) Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10–14. 24. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP (2004) Activation of airway epithelial cells by toll-like receptor agonists. Am J Resp Cell Mol 31: 358–364. 25. Wheeler DS, Catravas JD, Odoms K, Denenberg A, Malhotra V, et al. (2004) Epigallocatechin-3-gallate, a green tea–derived polyphenol, inhibits IL-1b- dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J Nutr 134: 1039–1044. 26. Wang X, Zhang Z, Louboutin J, Moser C, Weiner DJ, et al. (2003) Airway epithelia regulate expression of human b-defensin 2 through toll-like receptor 2. FASEB J 17: 1727–1729. 27. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, et al. (2000) Mucoid Pseudomonas aeruginosa, TNFa, and IL-1b, but not IL-6, induce human b-defensin-2 in respiratory epithelia. Am J Resp Cell Mol 22: 714–721. 28. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G (1976) A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17: 62–70. 29. Corbiere V, Dirix V, Norrenberg S, Cappello M, Remmelink M, et al. (2011) Phenotypic characteristics of human type II alveolar epithelial cells suitable for antigen presentation to T lymphocytes. Resp Res 12: 15. 30. Bermudez LE, Goodman J (1996) Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun 64: 1400–1406. 31. Birkness KA, Deslauriers M, Bartlett JH, White EH, King CH, et al. (1999) An in vitro tissue culture bilayer model to examine early events in Mycobacterium tuberculosis infection. Infect Immun 67: 653–658. 32. Garcia-Pereza BE, Mondrago-Flores R, Luna-Herrera J (2003) Internalization of Mycobacterium tuberculosis by macropinocytosis in non-phagocytic cells. Microb Pathog 35: 49–55. 33. Greco E, Santucci MB, Quintiliani G, Papi M, De Spirito M, et al. (2009) CpG oligodeoxynucleotides promote phospholipase D dependent phagolysosome maturation and intracellular mycobacterial killing in M. tuberculosis infected type II alveolar epithelial cells. Cell Immunol 259: 1–4. 34. Greco E, Santucci MB, Quintiliani G, Papi M, De Spirito M, et al. (2009) CpG oligodeoxynucleotides promote phospholipase D dependent phagolysosome maturation and intracellular mycobacterial killing in M. tuberculosis infected type II alveolar epithelial cells. Cell Immunol 259: 1–4. 35. Rivas-Santiago B, Schwander SK, Sarabia C, Diamond G, Klein-Patel ME, et al. (2005) Human b-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun 73: 4505–4511. 36. Kisich KO, Heifets L, Higgins M, Diamond G (2001) Antimycobacterial agent based on mRNA encoding human b-Defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect Immun 69: 2692–2699. 37. Jonsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C (2007) Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol 45: 1497–1504. PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29148